Observational studyBMC nephrology2024

Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study.

Shinya Kameda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.